Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $4.50

Aveanna Healthcare (NASDAQ:AVAH) had its price target increased by UBS Group from $3.20 to $4.50 in a research report report published on Friday,Benzinga reports. UBS Group currently has a sell rating on the stock.

Separately, Truist Financial reduced their price target on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research report on Monday, January 6th.

Aveanna Healthcare Price Performance

Shares of AVAH stock opened at $5.19 on Friday. The firm has a market cap of $1.00 billion, a PE ratio of -15.26 and a beta of 2.25. Aveanna Healthcare has a 1-year low of $2.11 and a 1-year high of $6.19. The company has a 50-day moving average of $4.56 and a two-hundred day moving average of $4.96.

Institutional Trading of Aveanna Healthcare

Several hedge funds have recently added to or reduced their stakes in AVAH. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $35,000. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC raised its holdings in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after acquiring an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd raised its holdings in Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after acquiring an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $57,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.